Literature DB >> 32039826

Investigation of key miRNAs and potential mechanisms in non-small cell lung cancer development from chronic obstructive pulmonary disease.

Tuba Denkçeken1, Elif Pala.   

Abstract

Lung cancer (LC) is the prominent cause of cancer-related death worldwide, and non-small cell lung cancer (NSCLC) represents approximately 85% of all diagnosed LC cases. It is stated that LC and chronic obstructive pulmonary disease (COPD) are directly linked at a molecular genetics level. Early diagnosis of LC is important for individuals affected by COPD. This study aims to construct a molecular network to discover molecules in NSCLC development from COPD. We downloaded the expression profiles of COPD patients from Gene Expression Omnibus database. The Database Annotation for Visualization and Integrated Discovery tool was utilized for enrichment analysis; STRING and Cytoscape were used for network construction. 15 hub genes were detected among 1517 differentially expressed genes (DEGs). Additionally, 20 differentially expressed miRNAswere identified from five datasets. We constructed miRNA-mRNA regulatory network between the groups of overlapping predicted target genes/DEGs and miRNAs that contained miRNA-mRNA pairs. UALCAN and OncomiR web-portals were used to validate hub genes and miRNAs in NSCLC. JUN, IL6, CD4 and hsa-miR-497-5p, hsa-miR-130b-5p were verified in both lung adenocarcinomas and lung squamous cell carcinomas. This study presents potential biomarkers and mechanisms underlying NSCLC development from COPD that would be targeted for early intervention.

Entities:  

Year:  2020        PMID: 32039826     DOI: 10.4149/gpb_2019042

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  2 in total

1.  Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.

Authors:  Amirhossein Fathinavid; Mohadeseh Zarei Ghobadi; Ali Najafi; Ali Masoudi-Nejad
Journal:  BMC Genom Data       Date:  2021-10-12

2.  MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.

Authors:  Jiangwei Hu; Xinqin Xiang; Wei Guan; Weihua Lou; Junming He; Jian Chen; Yin Fu; Guoliang Lou
Journal:  J Cardiothorac Surg       Date:  2021-11-12       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.